The Hub for Disease-Specific Clinical Information

Exploring the Mechanism of MTAP Regulation in Renal Cell Carcinoma

By: Alison Tewksbury
Posted: Wednesday, November 28, 2018

To further explore the mechanisms of methylthioadenosine phosphorylase (MTAP) on tumor suppression and regulation of renal cell carcinoma progression, Ching-Hsien Chen, PhD, of the University of California, Davis, and colleagues presented their genetic study findings at the American Society of Nephrology Kidney Week 2018 (Abstract FR-PO1033). They found that insulin growth factor 1 receptor (IGF-1R) appears to be a “driver pathway conferring [the] aggressive nature to MTAP-deleted kidney cancer.”

Immunohistochemistry and tissue microarray confirmed an inverse association between IGF-1R phosphorylation and MTAP expression; and Western blots showed an elevation of IGF-1R phosphorylation and signaling after MTAP knockout. Further testing was performed with an inhibitor of IFG-1R, linsitinib; after this treatment, a decrease in cell viability, migration, invasion, and colony-forming capabilities was noted by researchers.

This understanding of the relationship between MTAP-gene expression and IGF-1R signaling may help to further direct treatment in these types of renal cell carcinoma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.